Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing—an emerging strategy in cancer therapeutics
Khadija Shahab Turabi, Ankita Jaywant Deshmukh, Sayan Paul, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1139-1158
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The strategies to cure cancer patients by eradicating cancer stem-like cells
Yansui Mai, Jiyan Su, Chuan Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Challenges and Opportunities for Celecoxib Repurposing
Urszula Bąk, Anna Krupa
Pharmaceutical Research (2023) Vol. 40, Iss. 10, pp. 2329-2345
Open Access | Times Cited: 27
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
Robert Morris, Rahinatu Ali, Feng Cheng
Current Drug Targets (2024) Vol. 25, Iss. 7, pp. 454-464
Closed Access | Times Cited: 9
Expression of Helicobacter pylori CagA in Solanum melongena L-A Cost Effective Strategy for Vaccine Development
Mohammad Javad Mehran, Rambod Barzigar, Basaralu Yadurappa Sathish Kumar, et al.
Indian Journal of Pharmaceutical Education and Research (2025) Vol. 59, Iss. 1, pp. 196-209
Closed Access | Times Cited: 1
Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics
Mohan Rao, Eric McDuffie, Clifford Sachs
Toxics (2023) Vol. 11, Iss. 10, pp. 875-875
Open Access | Times Cited: 11
Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects
Maria Auxiliadora Parreiras Martins, Francisco Veiga, Ana Cláudia Paiva‐Santos, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells
Y. Terry Lee, Chang‐Gu Hyun
Molecules (2025) Vol. 30, Iss. 4, pp. 900-900
Open Access
Recent Advances in Medicinal Chemistry Strategies for the Development of METTL3 Inhibitors
G. Li, Wei Chen, Dan Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117560-117560
Closed Access
The global patent landscape of emerging infectious disease monkeypox
Yuanqi Cai, Xiaoming Zhang, Kuixing Zhang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Cytotoxicity and Cellular Uptake Capacity of a Berberine-Loaded Nanogold/Collagen Drug Delivery System in Lung Cancer
Chien‐Lun Tang, Chen-Feng Chiu, Shan‐hui Hsu, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 702, pp. 134961-134961
Closed Access | Times Cited: 3
The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing
Yousef A. Abdelrady, Hayam S. Thabet, Ahmed M. Sayed
Pharmacological Reports (2024)
Closed Access | Times Cited: 3
PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration
Zhenzhan Zhang, Donghua Huang, Junjie Feng, et al.
Deleted Journal (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 2
In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment
Ezgi Yağmur Tükel, Onur Ateş, Yağmur Kiraz
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Comparative analysis of tongue cancer organoids among patients identifies the heritable nature of minimal residual disease
Miwako Sase, Taku Sato, Hajime Sato, et al.
Developmental Cell (2024)
Closed Access | Times Cited: 2
Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells
Yulu Wang, Amit Sharma, Fangfang Ge, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach
Chin‐Mu Hsu, Kung‐Chao Chang, Tzer‐Ming Chuang, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4150-4150
Open Access | Times Cited: 5
Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration
Xiaojing Li, Peng Nie, Piet Herdewijn, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115928-115928
Closed Access | Times Cited: 5
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Navanath Kumbhar, Snehal Nimal, Deeksha Patil, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Repurposing GnRH-A as a Near-Infrared Fluorescent Probe for Diagnosis and Surgical Navigation of Breast Cancer Tumors and Metastases
Haoran Xu, Zhuoyi Ye, Xin Gao, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer
Valentina Piastra, Federica Ganci, Andrea Sacconi, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer
Fernanda Villarruel-Melquiades, Elizabeth Hernandez-Gallegos, Carmen Solano-Agama, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 1156-1163
Open Access | Times Cited: 3
In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
Amin Aliabadi, Mohammad Reza Haghshenas, Razie Kiani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 2379-2388
Closed Access | Times Cited: 2
AI/ML and drug repurposing in lung cancer: State of the art and potential roles for retinoids
Gabriele Sala, Davide La Torre, Marco Repetto, et al.
Elsevier eBooks (2024), pp. 47-61
Closed Access
AI‐Driven Drug Discovery and Repurposing for Analyzing Long‐Term Effects of Nerve Sliders and Tensioners on Quality of Life in Cervicogenic Headache Patients
Sapan Pandya, Manish K. Jha, Vaibhav Agarwal, et al.
(2024), pp. 159-179
Closed Access
Stable expression ofHelicobacter pylori cagAoncoprotein in brinjal
Mohammad Javad Mehran, Rambod Barzigar, Basaralu Yadurappa Sathish Kumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top